Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2023 08:00 ET | Source: Skyline Corporate Communications Group, LLC

Skyline Corporate Communications Group, LLC President, Scott Powell, Named by Business Insider Magazine as one of the Nation’s Top 18 Public Relations Executives

New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Skyline Corporate Communications Group, LLC, a consulting agency that provides customized corporate communications and strategic investor relations...
June 27, 2023 09:45 ET | Source: Ohmyhome Ltd.

Ohmyhome Ltd. Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services

SINGAPORE, June 27, 2023 (GLOBE NEWSWIRE) -- Ohmyhome Limited (“Ohmyhome” or the Company) (NASDAQ: OMH), a data-driven property technology company based in Singapore, today announced it has retained...
November 04, 2022 06:55 ET | Source: Castellum, Inc.

Castellum, Inc. Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services

POTOMAC, Md., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (“Castellum” or the “Company”) (NYSE American: CTM), a cybersecurity, electronic warfare, data analytics, software, and IT services...
August 31, 2022 08:00 ET | Source: Vyant Bio, Inc.

Vyant Bio to Present at the H.C. Wainwright 24th Annual Global Investment Conference

CHERRY HILL, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
August 15, 2022 08:05 ET | Source: Vyant Bio, Inc.

Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast

CHERRY HILL, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
June 01, 2022 18:05 ET | Source: Vyant Bio, Inc.

Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services

CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...